Table I.
Demographics of patients who presented with ACS (STEMI and NSTEMI) in March/April 2019 and March/April 2020
| STEMI and NSTEMI | |||||
|---|---|---|---|---|---|
| 2019 |
2020 |
||||
| N = 113 | N = 67 | P | [95% CI] | ||
| Age | Mean ± SD | 72.3 ± 14.2 | 65.1 ± 14.5 | .001* | [2.8,11.6] |
| Gender, N (%) | Male | 70 (61.9) | 47 (70.1) | .265** | |
| Female | 43 (38.1) | 20 (29.9) | |||
| Miles away From the hospital |
Mean ± SD | 19.2 ± 19.5 | 15.3 ± 15.5 | .171* | [−1.6,9.3] |
| Treatment, N (%) | PCI | 73 (64.6) | 57 (85.1) | .003** | |
| Medical Management | 40 (35.4) | 10 (14.9) | |||
| Onset of symptoms, N (%) | < 3 h | 21 (18.6) | 5 (7.5) | .072** | |
| < 6 h | 25 (22.1) | 9 (13.3) | |||
| 6–24 h | 41 (36.3) | 32 (47.8) | |||
| >24 h | 26 (23) | 21 (31.3) | |||
*Independent t test; **χ2 test.